47 results
PRE 14A
TYRA
Tyra Biosciences Inc
5 Apr 24
Preliminary proxy
4:20pm
on a deal for a promising immunotherapy), chairing significant global R&D alliances, and having responsibility for the launches of new medicines across … such changes in the future as it deems appropriate.
Role of Board in Risk Oversight Process
The Board has responsibility for the oversight of our risk
8-K
EX-10.1
TYRA
Tyra Biosciences Inc
5 Feb 24
Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing
6:05am
thereunder.
4.20 Insurance. The Company maintains insurance underwritten by insurers of recognized financial responsibility, of the types
S-3
EX-4.4
k8ifxqdw2 buok7j8
3 Oct 22
Shelf registration
4:05pm
S-3
EX-1.2
jb06s
3 Oct 22
Shelf registration
4:05pm
S-3
q0rry khvr7ic0
3 Oct 22
Shelf registration
4:05pm
DEF 14A
p6rrhre8
28 Apr 22
Definitive proxy
4:07pm
10-K
2q88m7b9l33qr
3 Mar 22
Annual report
4:31pm
10-K
EX-10.15
w3yu gaug
3 Mar 22
Annual report
4:31pm
10-K
EX-10.12
bkjy3dlv
3 Mar 22
Annual report
4:31pm
424B4
n0yyk
15 Sep 21
Prospectus supplement with pricing info
4:10pm
S-1/A
EX-10.2
l4858t0dqjx0f193zir
9 Sep 21
IPO registration (amended)
6:08am
S-1/A
3wbwlb5svvxp8jhzni
9 Sep 21
IPO registration (amended)
6:08am
S-1/A
EX-1.1
7xcun43pjdd1nc
9 Sep 21
IPO registration (amended)
6:08am
S-1
EX-10.12
humwfu3 rb
20 Aug 21
IPO registration
4:07pm